NCT04541303View on ClinicalTrials.gov

Topical Tranexamic Acid Use on Granulating Wounds Following Mohs Micrographic Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Postoperative Wound Haemorrhage
Interventions
DRUG

Tranexamic acid

tranexamic acid diluted to concentration of 25ml/mg

DRUG

normal saline

0.9% sodium chloride

Trial Locations (1)

65212

University of Missouri-Columbia, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT04541303 - Topical Tranexamic Acid Use on Granulating Wounds Following Mohs Micrographic Surgery | Biotech Hunter | Biotech Hunter